Skip to content

13F-HR filed by Pivotal bioVenture Partners Investment Advisor LLC

Pivotal bioVenture Partners Investment Advisor LLC filed this 13F-HR for the quarter ended 2025-09-30, filed 2025-11-13, with 10 holding rows worth $172,983,714.

Accession
0001012975-25-000748
Filed
2025-11-13
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2025

A holdings report, 10 entries on the cover page, a total value of $172,983,714 stated on the cover page (in dollars after the unit check, H1), rows summing to $172,983,714 with VALUE read as dollars as filed, 13F file number 028-20630. The quarter's positions are built on this report. The resolved quarter.

Other managers

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
VAXCYTE INC COM92243G108Stock1,372,425$49,434,749dollars as filed
OCULIS HOLDING AGH5870P102CMN2,300,774$40,447,607dollars as filed
ARCUTIS BIOTHERAPEUTICS INC03969K108COM2,120,508$39,971,576dollars as filed
ZENAS BIOPHARMA INC COM98937L105Stock779,045$17,294,799dollars as filed
TREVI THERAPEUTICS INC COM89532M101Stock1,256,782$11,499,555dollars as filed
IMMUNOME INC45257U108COM502,512$5,884,416dollars as filed
BIOAGE LABS INC COM09077V100Stock653,374$3,841,839dollars as filed
RECURSION PHARMACEUTICALS IN75629V104CL A595,518$2,906,128dollars as filed
RALLYBIO CORP75120L100COM2,404,644$1,199,917dollars as filed
BOLT BIOTHERAPEUTICS INC097702203COM NEW94,573$503,128dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001012975-25-000748this filing2025-11-13acceptance time not in the bulk data set